Keywords: Canada, Pharma economic impact, R&D investment, Rx&D, Clinical trials

Economic impact of Canada's innovative pharma sector exceeds C$3-billion

Article | 23 October 2012

Three new reports released by Canada’s Research-Based Pharmaceutical Companies (Rx&D) provide a combined snapshot of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in